Cargando…
Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
Schizophrenia (SCZ) and type 2 diabetes (T2D) are clinically associated, and common knowledge attributes this association to side effects of antipsychotic treatment. However, even drug-naive patients with SCZ are at increased risk for T2D. Dopamine dysfunction has a central role in SCZ. It is well-k...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872408/ https://www.ncbi.nlm.nih.gov/pubmed/27093067 http://dx.doi.org/10.1038/tp.2016.50 |